Newsig · Stock
MRNA (MRNA)
Measured reaction — 24h price move after each story
| Date | Max move | Net 24h | Story |
|---|---|---|---|
| 2026-10-02 | +5.52% | +0.85% | Moderna to join Nasdaq-100 index on Oct. 9, replacing Warner Bros. |
Latest stories mapped to MRNA
Everything Newsig has mapped to MRNA, newest first — no importance filter. Topic pages list critical and high-importance stories only.
- 2026-10-17 Moderna president Stephen Hoge sells $17m in stock
- 2026-10-16 Moderna retreats 8% amid valuation debate ahead of cancer data
- 2026-10-16 Moderna falls ahead of cancer vaccine data next week
- 2026-10-15 Moderna rallies despite bearish views ahead of cancer vaccine data
- 2026-10-13 BioNTech cancer drug misses key trial endpoint
- 2026-10-12 Pennsylvania records sixth measles death
- 2026-10-12 Moderna technical outlook: bullish trend meets near-term pullback
- 2026-10-09 Moderna gains 14% to set fresh 52-week high
- 2026-10-09 Moderna options activity surges as Nasdaq-100 inclusion and melanoma data drive call buying
- 2026-10-07 Tempus AI expands cancer therapy deal with Moderna, Merck
- 2026-10-07 Novavax and Moderna shares fall after plague concerns ease, Citi comments
- 2026-10-06 US appeals court weighs block on Kennedy’s vaccine panel appointments
- 2026-10-06 Novavax, Moderna cool as WHO downplays plague-related death in Russia
- 2026-10-05 New York declares disaster emergency over measles outbreak
- 2026-10-05 Pennsylvania measles cases rise to 1,004 as outbreak spreads
- 2026-10-05 What's next for personalized mRNA cancer vaccines?
- 2026-10-02 Moderna to replace Warner Bros Discovery on Nasdaq 100
- 2026-10-02 Moderna to join Nasdaq-100 index on Oct. 9, replacing Warner Bros.
- 2026-09-30 Pennsylvania reports 943 measles cases as outbreak grows
- 2026-09-30 4 stocks to watch on Wednesday: CAG, MRNA, SPCX, and WDAY
Open the live sentiment dashboard →
Curated by Newsig — News in. Signal out.
How the reaction data is measured · Editorial policy